TWST - Twist Bioscience Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-1.37%
S&P500 52-Week Change 322.69%
52 Week High 335.95
52 Week Low 319.64
50-Day Moving Average 323.08
200-Day Moving Average 325.58

Share Statistics

Avg Vol (3 month) 3316.33k
Avg Vol (10 day) 3362.08k
Shares Outstanding 533.26M
Float 22.51M
% Held by Insiders 117.11%
% Held by Institutions 161.74%
Shares Short (Dec 30, 2019) 44.3M
Short Ratio (Dec 30, 2019) 411.13
Short % of Float (Dec 30, 2019) 416.66%
Short % of Shares Outstanding (Dec 30, 2019) 412.93%
Shares Short (prior month Nov 28, 2019) 43.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2019
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin -197.98%
Operating Margin (ttm)-200.15%

Management Effectiveness

Return on Assets (ttm)-44.94%
Return on Equity (ttm)-89.07%

Income Statement

Revenue (ttm)54.38M
Revenue Per Share (ttm)1.98
Quarterly Revenue Growth (yoy)87.20%
Gross Profit (ttm)6.96M
EBITDA -102.94M
Net Income Avi to Common (ttm)-107.67M
Diluted EPS (ttm)-3.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)138.11M
Total Cash Per Share (mrq)4.17
Total Debt (mrq)7.73M
Total Debt/Equity (mrq)5.09
Current Ratio (mrq)5.28
Book Value Per Share (mrq)4.63

Cash Flow Statement

Operating Cash Flow (ttm)-87.94M
Levered Free Cash Flow (ttm)-62.16M